Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

ClinicalTrials.gov ID: NCT00428948

Public ClinicalTrials.gov record NCT00428948. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 1:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel-arm Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablets Regimens in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study's purpose is to evaluate the long-term safety and efficacy of tolvaptan versus placebo in patients with ADPKD.

Study identification

NCT ID
NCT00428948
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,445 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2007 (Type not available)
Primary completion
Jan 2012 (Actual)
Completion
Jan 2012 (Actual)
Last update posted
Jul 2, 2017

2007 – 2012

United States locations

U.S. sites
30
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Coastal Clinical Research Mobile Alabama 36608 —
University of South Alabama Mobile Alabama 36617 —
Apex Research of Riverside Riverside California 92503 —
Stanford University Medical Center Stanford California 94305-5114 —
University of Colorado Health Sciences Center Denver Colorado 80262 —
Yale University School of Medicine New Haven Connecticut 06510 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Coastal Nephrology Associates Research Center, LLC Port Charlotte Florida 33952 —
Emory University School of Medicine Atlanta Georgia 30308 —
Northwestern University Chicago Illinois 60611 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Renal Associates of Baton Rough, L.L.C. Baton Rouge Louisiana 70809 —
John Hopkins School of Medicine Baltimore Maryland 21205 —
Tufts- New England Medical Center Boston Massachusetts 02111 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Mayo Medical Center Rochester Minnesota 55905 —
Erie County Medical Center Buffalo New York 14215 —
Nephrology Associates of Westchester Hawthorne New York 10532 —
The Rogosin Institute New York New York 10021 —
Columbia University Medical Center New York New York 10032 —
University of North Carolina, UNC, Kidney Center Chapel Hill North Carolina 27599 —
East Carolina University Greenville North Carolina 27834 —
Kidney and Hypertension Center Cincinnati Ohio 45220 —
University Hospitals of Cleveland/Case Cleveland Ohio 44106 —
Northwest Renal Clinic, Inc. Portland Oregon 97210 —
University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104 —
Charleston Nephrology Associates Charleston South Carolina 29405 —
Nephrology Associates, P.C. Nashville Tennessee 37205 —
Vanderbilt University Medical Center Nashville Tennessee 37232-1371 —
University of Virginia, Nephrology Clinical Research Center Charlottesville Virginia 22908 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00428948, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2017 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00428948 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →